Related Experiment Video
Updated: Oct 22, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review
Ala-Eddine Deghmane1, Samy Taha1,2, Muhamed-Kheir Taha1
1Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and Haemophilus Influenzae, Paris, France.
Abstract:
Neisseria meningitidis (the meningococcus) causes significant morbidity and mortality worldwide through an epidemic or sporadic invasive infections. The epidemiology of N. meningitidis is changing and unpredictable. Certain emerging meningococcal genotypes seem to be associated with increasing unusual clinical presentations. Indeed, early symptoms may vary and are frequently non-specific. However, atypical clinical forms including abdominal presentations, septic arthritis, and bacteremic pneumonia may lead to misdiagnosis and some are usually associated with higher case fatality rates due to delayed optimal management. Improving awareness of clinicians and public health specialists about these unusual but potentially severe presentations should help establish prompt diagnoses and provide appropriate management of cases. In this review, we described unusual panels of clinical presentations of invasive meningococcal disease linked to the recent changes in meningococcal epidemiology.
Insights
Emerging meningococcal genotypes are linked to unusual invasive disease presentations. Increased clinician awareness of these atypical symptoms is crucial for prompt diagnosis and improved patient outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Neisseria meningitidis (meningococcus) is a major global cause of invasive infections, morbidity, and mortality.
- The epidemiology of meningococcal disease is dynamic and unpredictable, with evolving genotypes.
- Emerging meningococcal strains are associated with atypical clinical manifestations.
Purpose of the Study:
- To review unusual clinical presentations of invasive meningococcal disease.
- To highlight the link between changing meningococcal epidemiology and novel disease manifestations.
- To emphasize the need for enhanced clinician and public health awareness.
Main Methods:
- Literature review of invasive meningococcal disease cases.
- Analysis of clinical presentations associated with recent epidemiological shifts.
- Synthesis of information on emerging meningococcal genotypes and their clinical impact.
Main Results:
- Atypical presentations, including abdominal symptoms, septic arthritis, and bacteremic pneumonia, are increasingly recognized.
- These unusual forms can lead to misdiagnosis due to non-specific early symptoms.
- Delayed diagnosis of atypical meningococcal disease is associated with higher fatality rates.
Conclusions:
- Changes in meningococcal epidemiology are associated with a broader spectrum of clinical presentations.
- Clinicians and public health specialists require heightened awareness of these unusual presentations.
- Prompt recognition and management are essential for improving outcomes in invasive meningococcal disease.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Principles of Disease Surveillance
Endocarditis I: Introduction

